![Share on Facebook Facebook](http://kennyslaught.com/wp-content/plugins/social-media-feather/synved-social/image/social/regular/64x64/facebook.png)
![Share on Twitter twitter](http://kennyslaught.com/wp-content/plugins/social-media-feather/synved-social/image/social/regular/64x64/twitter.png)
![Pin it with Pinterest pinterest](http://kennyslaught.com/wp-content/plugins/social-media-feather/synved-social/image/social/regular/64x64/pinterest.png)
![Share on Linkedin linkedin](http://kennyslaught.com/wp-content/plugins/social-media-feather/synved-social/image/social/regular/64x64/linkedin.png)
David Low, a professor in UCSB’s Department of Molecular, Cellular, and Developmental Biology, will immerse himself in an innovative global health and development research project titled “Strategy for development of enteric pathogen-specific phage”. His research will directly focus on a new way to deal with serious bacterial pathogens as they become resistant to many once-powerful antibiotics. According to active UCSB Foundation member Kenny Slaught, “He will engineer phage to selectively target and destroy several pathogenic bacteria to prevent enteric diseases in infants”.
![Share on Facebook Facebook](http://kennyslaught.com/wp-content/plugins/social-media-feather/synved-social/image/social/regular/64x64/facebook.png)
![Share on Twitter twitter](http://kennyslaught.com/wp-content/plugins/social-media-feather/synved-social/image/social/regular/64x64/twitter.png)
![Pin it with Pinterest pinterest](http://kennyslaught.com/wp-content/plugins/social-media-feather/synved-social/image/social/regular/64x64/pinterest.png)
![Share on Linkedin linkedin](http://kennyslaught.com/wp-content/plugins/social-media-feather/synved-social/image/social/regular/64x64/linkedin.png)